Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Ethyldiamine orexin receptor antagonists

Ethyldiamine orexin receptor antagonists

US Patent 10011595 · Granted Jul 3, 2018

Estimated economic value: $73,356,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

5-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitors2025
6-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitors2025
4-amino or 4-alkoxy-substituted aryl sulfonamide compounds with selective activi2025
Heterobicyclic carboxylic acids and salts thereof2025
Substituted aminopyridine compounds as EGFR inhibitors2024
Substituted aminopyridine compounds as EGFR inhibitors2024
Tricyclic heterocycle compounds useful as HIV integrase inhibitors2024
Dihydroorotate dehydrogenase inhibitors2023
Aryl and heteroaryl ether derivatives as liver X receptor beta agonists, composi2023
Gene ANSB knockout mutant of citrobacter werkmanii and application thereof2023
Dihydroorotate dehydrogenase inhibitors2022
Oxadiazepinone derivatives and methods of treating hepatitis B infections2021